Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study
Malte Roar(Aalborg University Hospital), Tobias Sejbæk(University of Southern Denmark), Melinda Magyari(University of Copenhagen), Matthias Kant(Sygehus Sønderjylland), Rikke Ratzer(University of Copenhagen), Nasrin Asgari(University of Southern Denmark), Zsolt Illés(Universität Hamburg), Henrik Boye Jensen(Region of Southern Denmark), Ásta Theódórsdóttir(Rigshospitalet), Stig Wergeland(Haukeland University Hospital), Jette Lautrup Frederiksen(University of Copenhagen), Georgi Sirakov(Regional Hospital West Jutland), Louise Schlosser Mose(Hospital South West Jutland), Morten Stilund, Said Ashna(Zealand University Hospital), Hilde Nordborg(University of Bergen), Amalie Rhode Høgh Nielsen(Aalborg University), Finn Sellebjerg(Danish Multiple Sclerosis Center), Jakob Schäfer(Aalborg University Hospital), Jonas M. Berg(Regionshospitalet Viborg)
Cited by 3
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572